Loading the dossier
The Hill Wire · Member dossier
Mike Kennedy
RepublicanRepresentative · UT-3
Vice Chair, Natural Resources subcommittee on Federal LandsCurrent term began Jan 2025Quiet since Jun 2025
Fewer than five priced purchases on the record, so no comparison to the index is drawn.
- Disclosed trades
- 1
- 1 purchase · 0 sales · made public since January 2025
- Disclosed volume
- $8K
- midpoints of the reported ranges, not what Kennedy owns
- Made public
- 42 days
- Half of Kennedy's trades were made public within 42 days; Congress overall 28; the law allows 45.
- On time
- 100%
- 79% across Congress
A U.S. representative from Utah and a physician and attorney
Mike Kennedy is a physician, attorney, and politician. He served in the Utah House of Representatives from 2013 to 2019 and the Utah Senate from 2021 to 2025. He has represented Utah's 3rd congressional district in the U.S. House since 2025.
Kennedy's background as a physician and attorney brings professional experience in medicine and law, relevant to the health care and legal services sectors.
physician · attorney · former state legislator
Generated with AI, awaiting an editor · from Wikipedia · not from the filings
What the filings show
A Utah House Republican whose disclosed buying centers on Berkshire Hathaway
The disclosed buying centers on Berkshire Hathaway shares, leaving the reported activity narrowly focused in financials. Purchases follow a regular pace and are filed in Kennedy's own name, with no options reported. The record is too limited to establish a broader investing approach.
What to watch
- Further Berkshire Hathaway purchases would reinforce the narrow focus; other holdings could broaden the picture.
- Filings have met the reporting deadline, but the delay still separates disclosure from the trading decision.
- Reported activity belongs to Kennedy himself; any spouse or joint account disclosures would change whose decisions the record reflects.
Generated with AI, awaiting an editor, from the member’s own filings · carries no figures and makes no claim about performance
Public information from STOCK Act filings. Amounts are reported in ranges and shown as midpoints, filings arrive after the trades, and no personal profit or loss is disclosed. Not financial advice.